Predict your next investment

Venture Capital
polarispartners.com

See what CB Insights has to offer

Investments

856

Portfolio Exits

183

Funds

21

Service Providers

3

About Polaris Partners

Polaris Partners, formerly Polaris Venture Partners, is a multistage investor with proven experience in Healthcare, Technology and Consumer sectors. The partnership invests across all company lifecycle stages as lead or co-lead investor. Many of its companies have achieved great success. In 2012 alone, ten companies realized important partnership acquisitions, including Ascend Health (acquired by Universal Health Services) Avila Therapeutics (acquired by Celgene); deCODE Genetics (acquired by Amgen); and Mark Monitor (acquired by Thomson Reuters).

Polaris Partners Headquarter Location

One Marina Park Drive 10th Floor

Boston, Massachusetts, 2210,

United States

855-787-3500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Polaris Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Polaris Partners in 3 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

382 items

F

Food & Beverage

123 items

C

CB Insights Healthcare Smart Money Investors - 2020

25 items

Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.

Latest Polaris Partners News

Polaris Partners Leads USD126m Series A for Singapore’s Tessa Therapeutics

Jun 14, 2022

June 9, 2022 Source(s): Tessa Therapeutics Polaris Partners led a USD126m Series A for Tessa Therapeutics, a Singapore-based biotech developer for cancer treatments, with follow-on from Temasek, EDBI, Heliconia Capital and Heritas Capital. Read more Sign up

Polaris Partners Investments

856 Investments

Polaris Partners has made 856 investments. Their latest investment was in Tessa Therapeutics as part of their Series A on June 6, 2022.

CBI Logo

Polaris Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/9/2022

Series A

Tessa Therapeutics

$126M

Yes

2

3/24/2022

Series C

Podimetrics

$45M

No

10

3/8/2022

Series A - II

TRexBio

$26M

Yes

6

3/2/2022

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

2/15/2022

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/9/2022

3/24/2022

3/8/2022

3/2/2022

2/15/2022

Round

Series A

Series C

Series A - II

Unattributed VC - III

Series D

Company

Tessa Therapeutics

Podimetrics

TRexBio

Subscribe to see more

Subscribe to see more

Amount

$126M

$45M

$26M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

6

10

10

Polaris Partners Portfolio Exits

183 Portfolio Exits

Polaris Partners has 183 portfolio exits. Their latest portfolio exit was Profitero on May 03, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/3/2022

Acquired

$99M

5

2/2/2022

Acquired

$99M

1

1/26/2022

Acq - Pending

$99M

3

1/12/2022

Acq - Pending

Subscribe to see more

$99M

Subscribe to see more

10

12/21/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/3/2022

2/2/2022

1/26/2022

1/12/2022

12/21/2021

Exit

Acquired

Acquired

Acq - Pending

Acq - Pending

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

1

3

10

10

Polaris Partners Acquisitions

2 Acquisitions

Polaris Partners acquired 2 companies. Their latest acquisition was Promedior on July 15, 2006.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/15/2006

Series D

$99M

$64.4M

Acq - Fin

3/17/2005

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

7/15/2006

3/17/2005

Investment Stage

Series D

Series A

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$64.4M

$99M

Note

Acq - Fin

Subscribe to see more

Sources

10

Polaris Partners Fund History

21 Fund Histories

Polaris Partners has 21 funds, including Polaris Growth Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/17/2022

Polaris Growth Fund II

$285.74M

2

8/6/2018

Polaris Growth Fund I

Buyouts & Acquisitions

Closed

$175M

1

5/12/2017

Polaris Entrepreneurs' Fund VIII

$14.47M

1

5/4/2017

Polaris Partners VIII

Subscribe to see more

Subscribe to see more

$99M

10

5/26/2016

F48 Ventures

$99M

10

Closing Date

3/17/2022

8/6/2018

5/12/2017

5/4/2017

5/26/2016

Fund

Polaris Growth Fund II

Polaris Growth Fund I

Polaris Entrepreneurs' Fund VIII

Polaris Partners VIII

F48 Ventures

Fund Type

Buyouts & Acquisitions

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$285.74M

$175M

$14.47M

$99M

$99M

Sources

2

1

1

10

10

Polaris Partners Service Providers

4 Service Providers

Polaris Partners has 4 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Provider Type

Counsel

Subscribe to see more

Subscribe to see more

Service Type

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Polaris Partners Team

16 Team Members

Polaris Partners has 16 team members, including current Founding Partner, Jonathan A. Flint.

Name

Work History

Title

Status

Stephen D. Arnold

Founder

Current

Jonathan A. Flint

Founding Partner

Current

Amir Nashat

Managing General Partner, Managing Partner

Current

David Barrett

Calico, Pure Atria Software, Lotus Development, IBM, and Lotus Development Corporation

Managing Partner, General Partner

Current

Darren Carroll

Eli Lilly and Company, InnoCentive, and RealMed Corporation

Managing Partner

Current

Name

Stephen D. Arnold

Jonathan A. Flint

Amir Nashat

David Barrett

Darren Carroll

Work History

Calico, Pure Atria Software, Lotus Development, IBM, and Lotus Development Corporation

Eli Lilly and Company, InnoCentive, and RealMed Corporation

Title

Founder

Founding Partner

Managing General Partner, Managing Partner

Managing Partner, General Partner

Managing Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.